Patent 8716512 was granted and assigned to National Health Research Institutes on May, 2014 by the United States Patent and Trademark Office.
A method for preparing and purifying recombinant lipoprotein Ag473 of Neisseria meningitidis (NM) group B isolates. The method can be used in large-scale production of vaccines for Neisseria meningitidis (NM) group B.